no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
A single vaccination with an inactivated hepatitis A liposome vaccine induces protective antibodies after only two weeks
|
Just, M. |
|
1992 |
10 |
11 |
p. 737-739 3 p. |
article |
2 |
Biochemical and immunological characterization of a novel peptide carrier system using rotavirus VP6 particles
|
Frenchick, P.J. |
|
1992 |
10 |
11 |
p. 783-791 9 p. |
article |
3 |
B30-MDP, a synthetic muramyl dipeptide derivative for tumour vaccination to enhance antitumour immunity and antimetastatic effect in mice
|
Yung Choon Yoo, |
|
1992 |
10 |
11 |
p. 792-797 6 p. |
article |
4 |
Calendar
|
|
|
1992 |
10 |
11 |
p. 808- 1 p. |
article |
5 |
Cell wall protein (WI-1) obtained from Blastomyces dermatitidis; useful as a vaccine and in diagnosis of infection, especially by radioimmunoassay
|
|
|
1992 |
10 |
11 |
p. 806- 1 p. |
article |
6 |
Comparison of capsid protein VP1 of the viruses used for the production and challenge of foot-and-mouth disease vaccines in Spain
|
González, Miguel |
|
1992 |
10 |
11 |
p. 731-734 4 p. |
article |
7 |
Compulsory and non-compulsory immunizations: Contraindications perceived by medical practitioners
|
Zotti, Carla |
|
1992 |
10 |
11 |
p. 742-746 5 p. |
article |
8 |
Construction of synthetic immunogens: Use of T- and B-cell epitopes of CS and RESA proteins of Plasmodium falciparum
|
Ritu, G. |
|
1992 |
10 |
11 |
p. 761-765 5 p. |
article |
9 |
Effects of sample processing on the measurement of specific intestinal IgA immune responses
|
Forrest, Bruce D. |
|
1992 |
10 |
11 |
p. 802-805 4 p. |
article |
10 |
Experimental evaluation of antitoxic protective effect of new cholera vaccines in mice
|
Dragunsky, Evgenia M. |
|
1992 |
10 |
11 |
p. 735-736 2 p. |
article |
11 |
Genotypic and phenotypic characterization of an aroD deletion-attenuated Escherichia coli K12-Shigella flexneri hybrid vaccine expressing S. flexneri 2a somatic antigen
|
Newland, John W. |
|
1992 |
10 |
11 |
p. 766-776 11 p. |
article |
12 |
Hepatitis C virus CKS fusion protein; expression in e.g. Escherichia coli from new cloning vector with modified lac promoter
|
|
|
1992 |
10 |
11 |
p. 806- 1 p. |
article |
13 |
Human zona pellucida protein ZP3 and fragments; recombination sperm receptor glycoprotein 3 and antibody production for use as immuno-contraceptive vaccine
|
|
|
1992 |
10 |
11 |
p. 806- 1 p. |
article |
14 |
Immune response to hepatitis B vaccine in parenteral drug abusers
|
Rodrigo, J.M. |
|
1992 |
10 |
11 |
p. 798-801 4 p. |
article |
15 |
Inhibition of immune responses against rabies virus by monoclonal antibodies directed against rabies virus antigens
|
Schumacher, Carolin L. |
|
1992 |
10 |
11 |
p. 754-760 7 p. |
article |
16 |
Liposomes enhance the immunogenicity of reconstituted influenza virus A/PR/8 envelopes and the formation of protective antibody by influenza virus A/Sichuan/87 (H3N2) surface antigen
|
Gregoriadis, G. |
|
1992 |
10 |
11 |
p. 747-753 7 p. |
article |
17 |
New Bordetella pertussis vaccine; with purified filamentous hemagglutinin, detoxified lymphocytosis promoting factor and 69-kDa outer membrane protein antigen
|
|
|
1992 |
10 |
11 |
p. 807- 1 p. |
article |
18 |
New influenza virus vaccine comprises liposome; having surface protein of influenza virus, mumps virus or measles virus capable of binding to mucosal cell surface and free of active neuraminidase
|
|
|
1992 |
10 |
11 |
p. 806- 1 p. |
article |
19 |
New vaccine against invasive amoebiases; contains immuno-dominant surface antigen of Entamoeba histolytica obtained by gene cloning; monoclonal antibody production and use in diagnosis of infection
|
|
|
1992 |
10 |
11 |
p. 807- 1 p. |
article |
20 |
Purification and characterization of Epstein-Barr virus gp340/220 produced by a bovine papillomavirus virus expression vector system
|
Madej, Monika |
|
1992 |
10 |
11 |
p. 777-782 6 p. |
article |
21 |
Recombinant pox virus e.g. vaccinia virus, fowl-pox virus and canary-pox virus; expressing Japanese encephalitis virus, yellow fever virus or dengue virus envelope, membrane and non-structural protein use in recombinant vaccine
|
|
|
1992 |
10 |
11 |
p. 806- 1 p. |
article |
22 |
Recombinant versus plasma-derived hepatitis B vaccine: comparison of immunogenicity in medical students
|
Möst, Johannes |
|
1992 |
10 |
11 |
p. 740-741 2 p. |
article |
23 |
Vaccine for protection of poultry against Haemophilus paragallinarum infection; recombinant 38 kDa outer membrane protein production for use in fowl recombinant vaccine
|
|
|
1992 |
10 |
11 |
p. 807- 1 p. |
article |